Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

NCT01048983 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No accrual.

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Armodafinil
DRUG: Bupropion
DRUG: Minocycline
DRUG: Curcumin
BEHAVIORAL: Telephone Questionnaire

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]